首页> 美国卫生研究院文献>other >Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.

【2h】

Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.

机译：监测有风险或患有心血管疾病的患者脂质水平的最佳策略：具有统计和成本效益模型的系统评价。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUNDVarious lipid measurements in monitoring/screening programmes can be used, alone or in cardiovascular risk scores, to guide treatment for prevention of cardiovascular disease (CVD). Because some changes in lipids are due to variability rather than true change, the value of lipid-monitoring strategies needs evaluation.

机译：背景技术监测/筛查程序中的各种脂质测量可以单独使用或以心血管疾病风险分数使用，以指导预防心血管疾病（CVD）的治疗。由于脂质的某些变化是由于变异而不是真实的变化，因此需要对脂质监测策略的价值进行评估。

著录项

期刊名称 other
作者
Rafael Perera; Emily McFadden; Julie McLellan; Tom Lung; Philip Clarke; Teresa Pérez; Thomas Fanshawe; Andrew Dalton; Andrew Farmer; Paul Glasziou; Osamu Takahashi; John Stevens; Les Irwig; Jennifer Hirst; Sarah Stevens; Asuka Leslie; Sachiko Ohde; Gautam Deshpande; Kevin Urayama; Brian Shine; Richard Stevens;
展开▼
作者单位

展开▼
年(卷),期 -1(19),100
年度 -1
页码 1–402
总页数 4
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: best marker for monitoring and cost-effectiveness of different monitoring frequencies [J] . Perera?R, McFadden?E, McLellan?J, Health technology assessment: HTA . 2015,第100期

机译：监测有风险或患有心血管疾病的患者脂质水平的最佳策略：监测不同监测频率和成本效益的最佳标志
2. Determining optimal strategies for primary prevention of cardiovascular disease: systematic review, cost-effectiveness review and network meta-analysis protocol [J] . Olalekan A. Uthman, Lena Al-Khudairy, Chidozie U. Nduka, Systematic Reviews . 2020,第1期

机译：确定心血管疾病初步预防的最佳策略：系统审查，成本效益审查和网络元分析方案
3. Determining optimal strategies for primary prevention of cardiovascular disease: systematic review, cost-effectiveness review and network meta-analysis protocol [J] . Progress in Artificial Intelligence . 2020,第1期

机译：确定心血管疾病初期预防的最佳策略：系统审查，成本效益审查和网络元分析方案
4. Dyslipidemia in Patients with Coronary Heart Disease and Cardiovascular Disease Risk Stratified Filtering [C] . Chunhua Ma International Conference on Control, Automation and Artificial Intelligence . 2017

机译：患有冠心病和心血管疾病风险的血脂血症分层过滤
5. A review of the management of patients at risk for or diagnosed with venous thromboembolism (VTE) at an academic medical center; and the cost-effectiveness of diagnostic strategies for VTE [D] . Lee, Jung-Ah 2008

机译：在学术医学中心对有风险或被诊断患有静脉血栓栓塞（VTE）的患者的管理进行审查；和VTE诊断策略的成本效益
6. Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits TNF-α-Blocker ELISA kits and Promonitor® ELISA kits versus standard care in patients with Crohns disease: systematic reviews and economic modelling. [O] . Karoline Freeman, Martin Connock, Peter Auguste, -1

机译：使用治疗性监测肿瘤坏死因子α（TNF-α）抑制剂的临床有效性和成本效益LISA-TRACKER®酶联免疫吸附测定（ELISA）试剂盒TNF-α-BlockerELISA试剂盒和Promonitor®ELISA试剂盒与克罗恩病患者的标准护理：系统评价和经济模型。
7. Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling [O] . Perera, R, McFadden, E, McLellan, J, 2015

机译：监测有风险或患有心血管疾病的患者脂质水平的最佳策略：具有统计和成本效益模型的系统评价

Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.

摘要

著录项

相似文献

相关主题

期刊订阅